{"mainPropery":{"diseaseId":9147,"diseaseName":"Minimal change disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9147/minimal-change-disease","synonyms":["Idiopathic minimal change nephrotic syndrome","Minimal change nephrotic syndrome","Minimal change glomerulopathy","MCNS"],"synonyms-with-source":[{"name":"Idiopathic minimal change nephrotic syndrome"},{"name":"Minimal change nephrotic syndrome"},{"name":"Minimal change glomerulopathy"},{"name":"MCNS"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"}],"organizations":[{"resourceID":97,"resourceName":"National Kidney Foundation","abbreviation":"","address1":"30 East 33rd Street","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10016","country":"United States","phone":"212-889-2210","tty":"","tollFree":"800-622-9010","fax":"212-689-9261","email":"info@kidney.org","url":"https://www.kidney.org/","freeText":""},{"resourceID":2348,"resourceName":"NephCure Kidney International","abbreviation":"","address1":"150 S. Warner Road Suite 402 ","address2":"","address3":"","address4":"","address5":"","city":"King of Prussia","state":"PA","zip":"19406","country":"","phone":"1-866-NephCure (637-4287)","tty":"","tollFree":"","fax":"","email":"info@nephcure.org","url":"https://nephcure.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=PubMed&details_term=%28%28%28%28%28%28Minimal%5BTitle%5D%20AND%20change%5BTitle%5D%29%20AND%20nephrotic%20syndrome%5BTitle%5D%29%20AND%20hasabstract%5Btext%5D%29%20AND%20English%5BLang%5D%29%20AND%20%28%28%22human%22%5BMeSH%20Terms%5D%20OR%20%22hominidae%22%5BMeSH%20Terms%5D%29%20OR%20%22Human%22%5BMeSH%20Terms%5D%29%29%20AND%20%28%221998/08/29%2007.42%22%5BEDat%5D%20%3A%20%222003/08/28%2007.42%22%5BEDat%5D%29%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Minimal change disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Minimal+change+disease%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Minimal change disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":872,"resourceId":1578,"resourceName":"RDCRN - Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE)","descriptionText":"The <a href=' https://neptune-study.org/' target='_blank'>Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with focal and segmental glomerulosclerosis, minimal change disease, membranous nephropathy, and nephrotic syndrome, other or unspecified caused, through research. The Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE) has a registry for patients who wish to be contacted about clinical research opportunities. <br /><br />For more information on the registry see: <a href='https://neptune-study.org/get-involved/' target='_blank'>https://neptune-study.org/get-involved/</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000496.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/243348-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1563,"resourceId":2167,"resourceName":"National Kidney and Urologic Diseases Information Clearinghouse","descriptionText":"The <a href='https://www.niddk.nih.gov/research-funding/at-niddk/labs-branches/kidney-diseases-branch/kidney-disease-section/glomerular-disease-primer/selected-glomerular-diseases#minimal-change-disease' target='_blank'>National Kidney and Urologic Diseases Information Clearinghouse</a>  (NIDDK) conducts and supports research on a broad spectrum of diseases affecting public health. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1903,"resourceId":97,"resourceName":"National Kidney Foundation","descriptionText":"The <a href='https://www.kidney.org/atoz/content/minimal-change-disease' target='_blank'>National Kidney Foundation</a> offers an information page on Minimal change disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":5041,"questionText":"What is minimal change disease?","answerText":"<strong>Minimal change disease</strong> is a kidney disease in which there is damage to the filtering units of the kidney (glomeruli). It is the most common cause of <a href=\"https://medlineplus.gov/ency/article/000490.htm\" target=\"_blank\">nephrotic syndrome</a> in children.[14256][14257] Nephrotic syndrome is comprised of a group of symptoms including protein in the urine (proteinuria), low protein levels in the blood, high cholesterol and triglycerides, an increased risk for blood clots, and swelling.[1625] Other features of this disease include weight gain and a foamy appearance of the urine.[14257] The cause of minimal change disease is unknown, but it may occur following an allergic reaction or infection.[14256] Treatment&nbsp;may involve the use of steroids.[14256][14257]","dateModified":"2018-01-12T00:00:00"},"basicQuestions":[{"questionId":12517,"questionText":"How might minimal change disease be treated?","answerText":"Corticosteroids are typically the first line of treatment for minimal change disease. The fluid retention and high blood pressure that often accompanies minimal change disease may be treated with the use of&nbsp;<span style=\"font-size: 12pt;\">water pills (diuretics) in combination with a low sodium diet and b</span><span style=\"font-size: 12pt;\">lood pressure medications (such as a</span><span style=\"font-size: 12pt;\">ngiotensin-converting enzyme (ACE) inhibitors, a</span><span style=\"font-size: 12pt;\">ngiotensin II receptor blocker (ARB), calcium channel antagonists).</span><br />\r\n<br />\r\n<span style=\"font-size: 12pt;\">Other medications that may be used in instances of disease recurrence include those that are used to treat certain types of cancer&nbsp;(</span><a href=\"https://medlineplus.gov/druginfo/meds/a682080.html\" target=\"_blank\" style=\"font-size: 12pt;\">cyclophosphamide</a><span style=\"font-size: 12pt;\">,&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a682899.html\" target=\"_blank\" style=\"font-size: 12pt;\">chlorambucil</a><span style=\"font-size: 12pt;\">,&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a607038.html\" target=\"_blank\" style=\"font-size: 12pt;\">rituximab</a><span style=\"font-size: 12pt;\">) and those that suppress the immune system (</span><a href=\"https://medlineplus.gov/druginfo/meds/a601207.html\" target=\"_blank\" style=\"font-size: 12pt;\">cyclosporine</a><span style=\"font-size: 12pt;\">,&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a601117.html\" target=\"_blank\" style=\"font-size: 12pt;\">tacrolimus</a><span style=\"font-size: 12pt;\">,&nbsp;</span><a href=\"https://medlineplus.gov/druginfo/meds/a682167.html\" target=\"_blank\" style=\"font-size: 12pt;\">azathioprine</a><span style=\"font-size: 12pt;\">, mycophenolate mofetil).[14258][14259]</span><br />\r\n<br />\r\n<span style=\"font-size: 12pt;\">There is an increased risk for the formation of blood clots (</span>thromboembolic<span style=\"font-size: 12pt;\">&nbsp;events) and infection in individuals with minimal change disease. It is recommended that individuals with&nbsp;minimal change disease stay active and should a blood clot occur, they may be treated with blood thinners. Infections, such as&nbsp;<a href=\"https://medlineplus.gov/cellulitis.html\" target=\"_blank\">cellulitis</a>,&nbsp;<a href=\"https://medlineplus.gov/ency/article/001335.htm\" target=\"_blank\">peritonitis</a>, and pneumonia are common in individuals with&nbsp;minimal change disease and should be treated quickly.[14259]</span>","dateModified":"2018-01-12T16:12:00","resourceClassificationName":"Treatment","references":[{"referenceId":14258,"authors":"Meyrier A","articleTitle":"Treatment of minimal change disease in adults","bookWebsiteJournalTitle":"UpToDate","date":"July 5, 2016","volume":"","pages":"","url":"https://www.uptodate.com/contents/treatment-of-minimal-change-disease-in-adults","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14259,"authors":"Mansur A, Georgescu F, Lew S","articleTitle":"Minimal-Change Disease","bookWebsiteJournalTitle":"Medscape","date":"July 30, 2017","volume":"","pages":"","url":"https://emedicine.medscape.com/article/243348","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12518,"questionText":"What is the long-term outlook of minimal change disease?","answerText":"In individuals who are not treated, there is an increased risk for infection and blood clotting events. About 5-10% of untreated adults may have spontaneous remission (resolution) of disease within a few months.<br />\r\n<br />\r\nOne major indication of the long-term outcome of MCD is the initial response to corticosteroid treatment. About 80-95% of adults with MCD who receive treatment via corticosteroids experience complete remission of symptoms. About half of all adults treated for MCD have remission within four weeks, while 10-25% require longer treatment. MCD may recur or relapse in about half of all adults. This usually occurs within one year of treatment.[14258]<br />\r\n<br />\r\nDespite the potential for the disease to recur, the occurrence of kidney failure and end stage renal disease is rare.[14258][14259]","dateModified":"2018-01-12T16:20:00","resourceClassificationName":"Prognosis","references":[{"referenceId":14258,"authors":"Meyrier A","articleTitle":"Treatment of minimal change disease in adults","bookWebsiteJournalTitle":"UpToDate","date":"July 5, 2016","volume":"","pages":"","url":"https://www.uptodate.com/contents/treatment-of-minimal-change-disease-in-adults","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14259,"authors":"Mansur A, Georgescu F, Lew S","articleTitle":"Minimal-Change Disease","bookWebsiteJournalTitle":"Medscape","date":"July 30, 2017","volume":"","pages":"","url":"https://emedicine.medscape.com/article/243348","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12136,"relatedDiseaseName":"C1q nephropathy","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":9580,"relatedDiseaseName":"Mesangial proliferative glomerulonephritis","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Minimal_change_disease"}